Clinical Advisory Statement. Importance of systolic blood pressure in older Americans

scientific article

Clinical Advisory Statement. Importance of systolic blood pressure in older Americans is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1161/01.HYP.35.5.1021
P698PubMed publication ID10818056

P2093author name stringD Levy
H R Black
J L Izzo
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectsystoleQ496359
P304page(s)1021-1024
P577publication date2000-05-01
P1433published inHypertensionQ5958695
P1476titleClinical Advisory Statement. Importance of systolic blood pressure in older Americans
P478volume35

Reverse relations

cites work (P2860)
Q6381173770-year legacy of the Framingham Heart Study
Q53646825A 3-year follow-up study on the risk of stroke among patients with conjunctival haemorrhage.
Q53281791A Systematic Review of Community Pharmacists' Interventions in Reducing Major Risk Factors for Cardiovascular Disease.
Q73280063A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged > or = 65 years with mild to moderate hypertension
Q36100478A prospective study of hypertension and risk of uterine leiomyomata.
Q30493506Acute episodes of predator exposure in conjunction with chronic social instability as an animal model of post-traumatic stress disorder
Q58043206Age-Dependent Association of the Polymorphisms in the Mitochondria-Shaping Gene, OPA1, With Blood Pressure and Hypertension in Korean Population
Q79209136Aggressive blood pressure control in general practice (ABC-GP) study: can the new targets be reached?
Q47302802Agreement between finger plethysmography- and brachial oscillometry-derived blood pressure measurements
Q33802590Alterations of pulse pressure stimulate arterial wall matrix remodeling
Q34659813An almond-enriched diet increases plasma α-tocopherol and improves vascular function but does not affect oxidative stress markers or lipid levels.
Q36503368Angiotensin II antagonists: clinical experience in the treatment of hypertension, prevention of cardiovascular outcomes and renal protection in diabetic nephropathy and proteinuria
Q37803362Are there benefits of antihypertensive therapy beyond blood pressure lowering?
Q36745562Artery buckling: new phenotypes, models, and applications
Q36632123Assessing the effects of non-steroidal anti-inflammatory drugs on antihypertensive drug therapy using post-marketing surveillance database
Q33933733Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use.
Q35795083Baseline medication adherence and blood pressure in a 24-month longitudinal hypertension study
Q46421135Biodemography: new approaches to understanding trends and differences in population health and mortality.
Q37323794Biomarkers related to aging in human populations.
Q35876466Blood pressure and progression of chronic kidney disease: importance of systolic, diastolic, or diurnal variation
Q34509411Blood pressure as a surrogate end point for hypertension
Q37152530Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease
Q37593677Blood pressure control in the elderly: can you have too much of a good thing?
Q35060141Blood pressure trajectories prior to death in patients with diabetes.
Q36536160Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: effectiveness in combination with diuretics or beta-blockers for treating hypertension
Q40715158Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012.
Q37418437Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study.
Q44512007Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats.
Q91559989Central blood pressure and pulse wave velocity in young and middle-aged Japanese adults with isolated systolic hypertension
Q35013807Clinical impact of renin-angiotensin system blockade: angiotensin-converting enzyme inhibitors vs. angiotensin receptor antagonists
Q48442332Clinical predictors of the response to short-term thiazide treatment in nondiabetic essential hypertensives
Q37779805Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide
Q35066109Comparative prognostic value of systolic, diastolic, and pulse pressure.
Q36038531Control of hypertension in eastern saudi arabia: results of screening campaign
Q49043410Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension
Q91642874Effective coverage for hypertension treatment among middle-aged adults and the older population in China, 2011 to 2013: A nationwide longitudinal study
Q34574399Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema
Q46965412Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study
Q46823672Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy
Q64128637Elevated blood pressure among U.S. adults with diabetes, 1988-1994
Q48727534Expanding the definition and classification of hypertension
Q35590906Fetal origin of vascular aging
Q30543372Fixed combination lisinopril plus hydro-chlorothiazide in the treatment of essential arterial hypertension: an opened, multi-centre, prospective clinical trial
Q38544207Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?
Q47915689Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing
Q35965890Health Insurance Coverage and Hypertension Control in China: Results from the China Health and Nutrition Survey.
Q52000855Health care cost of analgesic use in hypertensive patients.
Q34199999How long should telomeres be?
Q46612150How should COMET influence heart failure practice?
Q35108210How well are we managing and monitoring high blood pressure?
Q79613532Hypertension and peripheral arterial disease
Q37050159Hypertension control in the elderly
Q35185094Hypertension in the elderly: Are we all on the same wavelength?
Q34584216Hypertension in the elderly: a review of the importance of systolic blood pressure elevation
Q34722769Hypertension knowledge, awareness, and attitudes in a hypertensive population
Q91807470Impact of community based screening for hypertension on blood pressure after two years: regression discontinuity analysis in a national cohort of older adults in China
Q39705952Improved blood pressure control with a physician-nurse team and home blood pressure measurement
Q36615562Improved lipids, diastolic pressure and kidney function are potential contributors to familial longevity: a study on 60 Chinese centenarian families
Q95300991Indian guidelines on hypertension-IV (2019)
Q38844317Is Chinese herbal medicine effective for elderly isolated systolic hypertension? A systematic review and meta-analysis.
Q44401500Is systolic blood pressure sufficient for classification of blood pressure and determination of hypertension based on JNC-VI in an Iranian adult population? Tehran lipid and glucose study (TLGS).
Q38735436Isolated Systolic Hypertension in Young Individuals: Pathophysiological Mechanisms, Prognostic Significance, and Clinical Implications
Q77491750Isolated Systolic Hypertension in the Elderly
Q64985803Isolated systolic hypertension of the young and its association with central blood pressure in a large multi-ethnic population. The HELIUS study.
Q36718515Knowledge, Awareness and Self-Care Practices of Hypertension Among Cardiac Hypertensive Patients
Q33568472Kā-HOLO Project: a protocol for a randomized controlled trial of a native cultural dance program for cardiovascular disease prevention in Native Hawaiians
Q37145695Long-acting nifedipine in the management of the hypertensive patient
Q46155651Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men.
Q37388460Management of hypertension in the elderly patient
Q35886386Managing high-risk patients with hypertension: focus on the renin-angiotensin system
Q27011805Managing hypertension in the elderly: a common chronic disease with increasing age
Q35892516Mechanical buckling of artery under pulsatile pressure
Q64255816Mediterranean-Style Diet Improves Systolic Blood Pressure and Arterial Stiffness in Older Adults
Q36404975Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
Q37629587Models for estimating the metabolic syndrome biological age as the new index for evaluation and management of metabolic syndrome
Q37444168Nonpharmacological approaches in the management of hypertension
Q37499002Now or never: optimal antihypertensive therapy in the elderly
Q48531617Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997.
Q36013049Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
Q46148642Patient knowledge and awareness of hypertension is suboptimal: results from a large health maintenance organization
Q34584210Physician practice patterns in the treatment of isolated systolic hypertension in a primary care setting
Q39377506Predictors of uncontrolled hypertension in the Stroke Belt.
Q34179007Prehypertension: Underlying pathology and therapeutic options
Q36905032Prehypertension: demographics, pathophysiology, and treatment
Q44827601Prevalence and changes of untreated isolated systolic hypertension among non-Hispanic black adults in the United States
Q36069784Prevalence and trends of isolated systolic hypertension among untreated adults in the United States
Q33837558Prevalence of high blood pressure subtypes and its associations with BMI in Chinese children: a national cross-sectional survey.
Q37126630Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older
Q57605466Prevalence, awareness, treatment and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study
Q44727708Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex.
Q36893345Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension
Q48070348Randomized controlled trial of a multipronged intervention to improve blood pressure control among stroke survivors in Nigeria
Q35904468Reactivity to a Spouse's Interpersonal Suffering in Late Life Marriage: A Mixed-Methods Approach
Q35024225Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
Q33905072Relationship between psychosocial stress and hypertension among Ghanaians in Amsterdam, the Netherlands--the GHAIA study
Q53317541Religious orientation, aging, and blood pressure reactivity to interpersonal and cognitive stressors.
Q46866932Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension
Q26766525Salt Reduction Interventions in Sub-Saharan Africa: A Systematic Review
Q40692467Screening for eligibility in the study of antihypertensive medication in children: experience from the Ziac Pediatric Hypertension Study
Q53712224Self-management approaches among hypertensive residents in nursing homes in Malaysia.
Q92535598Serious adverse events in patients with target-oriented blood pressure management: a systematic review
Q53424333Should beta blockers be used in the treatment of hypertension in the elderly?
Q43407887Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II.
Q44809195Stagnation and the critical need for hypertension subtyping
Q34661282Stress as a potential modifier of the impact of lead levels on blood pressure: the normative aging study
Q44445417Systolic Hypertension in Hemodialysis Patients
Q42780149Systolic blood pressure
Q36812916Systolic blood pressure and adiposity: examination by race and gender in a nationally representative sample of young adults
Q73137702Systolic blood pressure elevation: it's where the action is
Q44003893Systolic vs diastolic blood pressure: community burden and impact on blood pressure staging
Q34140863Telomeres: the time factor in essential hypertension
Q73592652The Importance of Systolic Blood Pressure Control and Cardiovascular Disease Prevention
Q44001365The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study
Q36247350The association of educational attainment and SBP among older community-living adults: the Maintenance of Balance, Independent Living, Intellect and Zest in the Elderly (MOBILIZE) Boston Study
Q35162676The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression
Q30658320The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988--1994.
Q34209022The economic impact of hypertension
Q36515508The older patient with hypertension: care and cure
Q34158075The prevalence and heterogeneity of prehypertension: a meta-analysis and meta-regression of published literature worldwide
Q39501461Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study
Q37486470Transgenerational effect of fetal programming on vascular phenotype and reactivity in endothelial nitric oxide synthase knockout mouse model
Q24239956Treatment blood pressure targets for hypertension
Q35215068Treatment of hypertension in older patients: an updated look at the role of calcium antagonists
Q36590817Treatment of isolated systolic hypertension
Q35905180Treatment of systolic hypertension: spotlight on recent studies with angiotensin II antagonists
Q50753534Trends in hypertension-related death in the United States: 1980-1998.
Q35062333Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention
Q64234857Undiagnosed Isolated Systolic and Diastolic Hypertension Subtypes and Their Correlates in Bangladesh: A Nationwide Survey
Q34283117Update in pharmacologic treatment of hypertension
Q36557652Vascular Health in American Football Players: Cardiovascular Risk Increased in Division III Players
Q35108207What is the most important component of blood pressure: systolic, diastolic or pulse pressure?
Q80871629[Arterial hypertension, chronic renal insufficiency and dialysis]

Search more.